Weigh Pros and Cons of Meds for Primary Prevention of Breast Cancer

November 2019

You'll see renewed interest in meds to prevent breast cancer...due to updated U.S. Preventive Services Task Force recommendations.

Use shared decision-making to discuss prevention for women over 35 with other risks, such as atypical hyperplasia or a first-degree relative with breast cancer...or for BRCA mutation carriers who don't want surgery.

Tell women to expect hot flashes with any preventive option. And explain that they'll need to take these meds for 5 years.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Med Safety Put Concerns About Ranitidine and Drug Safety in Perspective
Heart Failure Don't Jump to an SGLT2 Inhibitor for Heart Failure
Medicare Avoid Pitfalls With Medicare Rxs for DME
Diabetes Temper Buzz About the First Oral GLP-1 Agonist, Rybelsus
Diabetes Compare Baqsimi or Gvoke With IM Glucagon for Severe Hypoglycemia
HIV & AIDS Know How Descovy and Truvada Stack Up for HIV Pre-Exposure Prophylaxis (PrEP)
Alcohol Be Ready to Answer the Question, "Is It Okay to Drink Alcohol With This Med?"
Pain Management Consider Acute Pain Management Options for Patients on Buprenorphine/Naloxone
Breast Cancer Weigh Pros and Cons of Meds for Primary Prevention of Breast Cancer
Dermatology Set Realistic Expectations for Patients Asking About Scar Treatments

Weigh Pros and Cons of Meds for Primary Prevention of Breast Cancer

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents